Cracowski Jean-Luc
Cracowski Jean-Luc
Professor of Pharmacology
Verified email at
Cited by
Cited by
Methodological issues in the assessment of skin microvascular endothelial function in humans
JL Cracowski, CT Minson, M Salvat-Melis, JR Halliwill
Trends in pharmacological sciences 27 (9), 503-508, 2006
Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications
JL Cracowski, T Durand, G Bessard
Trends in pharmacological sciences 23 (8), 360-366, 2002
Non‐invasive assessment of skin microvascular function in humans: an insight into methods
Microcirculation 19 (1), 47-64, 2012
Assessment of endothelial and neurovascular function in human skin microcirculation
M Roustit, JL Cracowski
Trends in pharmacological sciences 34 (7), 373-384, 2013
Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies
J Avouac, P Airò, C Meune, L Beretta, P Dieude, P Caramaschi, K Tiev, ...
The Journal of rheumatology 37 (11), 2290-2298, 2010
Chronic vagus nerve stimulation in Crohn's disease: a 6‐month follow‐up pilot study
B Bonaz, V Sinniger, D Hoffmann, D Clarencon, N Mathieu, C Dantzer, ...
Neurogastroenterology & Motility 28 (6), 948-953, 2016
Excellent reproducibility of laser speckle contrast imaging to assess skin microvascular reactivity
M Roustit, C Millet, S Blaise, B Dufournet, JL Cracowski
Microvascular research 80 (3), 505-511, 2010
Genome-Wide Scan Identifies TNIP1, PSORS1C1, and RHOB as Novel Risk Loci for Systemic Sclerosis
Y Allanore, M Saad, P Dieudé, J Avouac, JHW Distler, P Amouyel, ...
PLoS genetics 7 (7), e1002091, 2011
Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis
P Dieudé, M Guedj, J Wipff, J Avouac, I Fajardy, E Diot, B Granel, J Sibilia, ...
Arthritis & Rheumatism 60 (1), 225-233, 2009
Reproducibility and methodological issues of skin post-occlusive and thermal hyperemia assessed by single-point laser Doppler flowmetry
M Roustit, S Blaise, C Millet, JL Cracowski
Microvascular research 79 (2), 102-108, 2010
Increased lipid peroxidation in patients with pulmonary hypertension
JL Cracowski, C Cracowski, G BESSARD, JL Pepin, J Bessard, ...
American journal of respiratory and critical care medicine 164 (6), 1038-1042, 2001
Prostanoids contribute to cutaneous active vasodilation in humans
GR McCord, JL Cracowski, CT Minson
American Journal of Physiology-Regulatory, Integrative and Comparative …, 2006
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis
P de Groote, V Gressin, E Hachulla, P Carpentier, L Guillevin, A Kahan, ...
Annals of the rheumatic diseases 67 (1), 31-36, 2008
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis
P Dieudé, M Guedj, J Wipff, B Ruiz, E Hachulla, E Diot, B Granel, J Sibilia, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials
M Roustit, S Blaise, Y Allanore, PH Carpentier, E Caglayan, JL Cracowski
Annals of the rheumatic diseases 72 (10), 1696-1699, 2013
Vascular biology of the isoprostanes
JL Cracowski, P Devillier, T Durand, F Stanke-Labesque, G Bessard
Journal of vascular research 38 (2), 93-103, 2001
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population
P Dieude, M Guedj, J Wipff, B Ruiz, G Riemekasten, M Matucci-Cerinic, ...
Annals of the rheumatic diseases 69 (11), 1958-1964, 2010
Phenotypic determinants of uncontrolled asthma
V Siroux, A Boudier, J Bousquet, JL Bresson, JL Cracowski, J Ferran, ...
Journal of Allergy and Clinical Immunology 124 (4), 681-687. e3, 2009
Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension
JL Cracowski, JP Baguet, O Ormezzano, J Bessard, F Stanke-Labesque, ...
Hypertension 41 (2), 286-288, 2003
BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4
P Dieudé, J Wipff, M Guedj, B Ruiz, I Melchers, E Hachulla, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
The system can't perform the operation now. Try again later.
Articles 1–20